Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

EconomyDaily Composite
ShareXFacebook

To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement